centchroman has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulkareem, AO; Chanda, D; Gupta, S; Hanif, K; Iqbal, H; Jagavelu, K; Jha, RK; Lone, ZR; Tiwari, P | 1 |
| Culig, Z | 1 |
1 review(s) available for centchroman and Inflammation
| Article | Year |
|---|---|
Epithelial mesenchymal transition and resistance in endocrine-related cancers.
Topics: Benzopyrans; Breast Neoplasms; Cadherins; Cell Plasticity; Cytokines; Disease Progression; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Female; Humans; Inflammation; Male; MAP Kinase Kinase 5; Metformin; MicroRNAs; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Receptor, ErbB-2; Signal Transduction; Transforming Growth Factor beta | 2019 |
1 other study(ies) available for centchroman and Inflammation
| Article | Year |
|---|---|
Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension.
Topics: Animals; Estradiol; Estrogen Receptor alpha; Female; Humans; Hypertension, Pulmonary; Hypoxia; Inflammation; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators | 2023 |